Simplex Trading’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Simplex Trading’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-23	Closed	-$5K	–	7276
2017 Q3	$5K	Sell	23 -18	-44%	-$199	﹤0.01%	4491
2017 Q2	$4K	Buy	+41	New	+$410	﹤0.01%	4879
2017 Q1	–	Sell	-75	Closed	-$2K	–	7258
2016 Q4	$2K	Buy	+75	New	+$750	﹤0.01%	5240
2016 Q2	–	Sell	-9	Closed	-$4K	–	6891
2016 Q1	$4K	Buy	+9	New	+$80	﹤0.01%	4367
2015 Q1	–	Sell	-57	Closed	-$3K	–	6048
2014 Q4	$3K	Buy	+57	New	+$461	﹤0.01%	3608

Simplex Trading's SCLN Position: Q4 2017 in Review

Simplex Trading sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 23 shares.

Simplex Trading first reported a position in SCLN in Q4 2014 and held it in 8 quarters. The position peaked at $56K in Q1 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Simplex Trading reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Simplex Trading sold 23 Sciclone Pharmaceuticals Inc shares in Q4 2017.
Simplex Trading first reported a position in Sciclone Pharmaceuticals Inc in Q4 2014 and held it in 8 quarters.
Simplex Trading's Sciclone Pharmaceuticals Inc position peaked at $56K in Q1 2016.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Simplex Trading's 13F filing for Q4 2017, filed 10 Jan 2018.